Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
Randomized Controlled Trial
. 2018 Apr;44:300-305.
doi: 10.1016/j.jcrc.2017.08.040. Epub 2017 Sep 12.

The Study of Vitamin D Administration Effect on CRP and Interleukin-6 as Prognostic Biomarkers of Ventilator Associated Pneumonia

Affiliations
Randomized Controlled Trial

The Study of Vitamin D Administration Effect on CRP and Interleukin-6 as Prognostic Biomarkers of Ventilator Associated Pneumonia

Amir Ebrahim Miroliaee et al. J Crit Care. .

Abstract

Purpose: In regard with the effect of immune-stimulants in the treatment of infectious diseases, the effect of vitamin D administration on the outcome of patients with Ventilator-Associated Pneumonia (VAP) with a high rate of mortality, was studied.

Material and method: In this trial, 46 adult patients suffering from VAP and vitamin D deficiency were enrolled. The first group of patients received single intramuscular injection of vitamin D (300000Unit), while the other group were given the placebo.

Results: Administration of vitamin D significantly enhanced its levels (P<0.0001) in the treated patients (12.28±8.26) in comparison with placebo group (1.15±1.50). Serum Interleukin-6 levels were significantly reduced in the treated group compared to placebo (P=0.01). Although C-Reactive protein (CRP) levels showed an improving trend in the vitamin D group, no significant difference between groups (P=0.12) was found. Interestingly, the mortality rate of patients that treated with vitamin D (5/24) was significantly lower (p=0.04) than that of the placebo group (11/22).

Conclusion: Our results indicate that vitamin D administration can significantly reduce the IL-6 as prognostic marker in VAP patients, and must be considered as adjunct option in the treatment of VAP patients.

Similar articles

See all similar articles

Cited by 2 articles

Publication types

MeSH terms

Feedback